Applied Clinical Trials-09-01-2024

Click the title above for a link to open the Applied Clinical Trials September 2024 issue in an interactive PDF format.

Amid the steady introduction of new tech and data advances in study conduct, the September issue of Applied Clinical Trials explores the evolving regulatory landscape governing these efforts and what companies are doing to remain compliant.

The promise and acceptance of using this AI tool in drug development is growing.

Compliance with diverse clinical trial payment and data standards requires specialized skills.

Preventing delays and accelerating the progression of these critical therapies.

A look at the insights and implications surrounding the agency's recommendations on using RWE from electronic health records and medical claims data.

Gathering hard evidence on the benefits and risks of DCT solutions.

The key approaches today in unlocking the door to study inclusivity. Hint: they all prioritize participants.

Analysis confirms there is a relatively high degree of variability in risk planning results across studies.

By embracing this leadership approach, clinical research stakeholders can prioritize more effective staff training and readiness.

There is significant potential in decentralized models and digital health technology to expand diversity in clinical trials.